Yoos H Lorrie, Kitzman Harriet, Henderson Charles, McMullen Ann, Sidora-Arcoleo Kimberly, Halterman Jill S, Anson Elizabeth
University of Rochester School of Nursing, University of Rochester School of Medicine and Dentistry, New York, USA.
Nurs Res. 2007 May-Jun;56(3):167-74. doi: 10.1097/01.NNR.0000270023.44618.a7.
Despite significant advances in treatment modalities, morbidity due to childhood asthma has continued to increase, particularly for poor and minority children.
To describe the parental illness representation of asthma in juxtaposition to the professional model of asthma and to evaluate the impact of that illness representation on the adequacy of the child's medication regimen.
Parents (n = 228) of children with asthma were interviewed regarding illness beliefs using a semistructured interview. The impact of background characteristics, parental beliefs, the child's symptom interpretation, and the parent-healthcare provider (HCP) relationship on the adequacy of the child's medication regimen were evaluated.
The parental and professional models of asthma differ markedly. Demographic risk factors (p = .005), low parental education (p < .0001), inaccurate symptom evaluation by the child (p = .02), and a poor parent-HCP relationship (p < .0001) had a negative effect on the parental illness representation. A parental illness representation concordant with the professional model of asthma (p = .05) and more formal asthma education (p = .02) had a direct positive effect on the medication regimen. Demographic risk factors (p = .006) and informal advice-seeking (p = .0003) had a negative impact on the regimen. The parental illness representation mediated the impact of demographic risk factors (p = .10), parental education (p =.07), and the parent-HCP relationship (p = .06) on the regimen.
Parents and HCPs may come to the clinical encounter with markedly different illness representations. Establishing a partnership with parents by eliciting and acknowledging parental beliefs is an important component of improving disease management.
尽管治疗方式取得了显著进展,但儿童哮喘的发病率仍在持续上升,尤其是贫困和少数族裔儿童。
将哮喘的家长疾病认知模式与专业哮喘模式并列描述,并评估该疾病认知模式对儿童药物治疗方案适当性的影响。
采用半结构化访谈,就疾病信念对228名哮喘儿童的家长进行了访谈。评估了背景特征、家长信念、儿童症状解读以及家长与医疗保健提供者(HCP)关系对儿童药物治疗方案适当性的影响。
哮喘的家长模式与专业模式存在显著差异。人口统计学风险因素(p = 0.005)、家长教育程度低(p < 0.0001)、儿童对症状评估不准确(p = 0.02)以及家长与HCP关系不佳(p < 0.0001)对家长疾病认知产生负面影响。与专业哮喘模式一致的家长疾病认知(p = 0.05)以及更正规的哮喘教育(p = 0.02)对药物治疗方案有直接的积极影响。人口统计学风险因素(p = 0.006)和寻求非正式建议(p = 0.0003)对治疗方案有负面影响。家长疾病认知介导了人口统计学风险因素(p = 0.10)、家长教育程度(p = 0.07)和家长与HCP关系(p = 0.06)对治疗方案的影响。
家长和HCP在临床接触时可能会有明显不同的疾病认知。通过引出并认可家长信念与家长建立伙伴关系是改善疾病管理的重要组成部分。